Thermo Fisher Scientific (TMO) Q4 FY25 earnings call

Thermo Fisher Scientific concluded FY25 with a strong fourth quarter, demonstrating agility in navigating evolving market conditions and delivering robust earnings growth. The company's proven growth strategy, underpinned by high-impact innovation and the PPI Business System, drove share gains and operational excellence. Strategic capital deployment, including significant M&A and shareholder returns, further strengthened its competitive position, setting the stage for continued strong performance in FY26.